ZBIO

Zenas BioPharma, Inc. $28.39 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.5%
Next 1 week
+1.9%
Next 1 month
+1.2%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 50
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.80%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.50 +1.2%
$14M/day volume 95% volatility +1% 1-year -36% from ATH
52-week range · 48% of the way up · -36% from the high
$13.50$44.60

Earnings Full history →

Next report 2026-11-12 (Thursday, before open, in 10 days) · EPS est. -1.27.

Biggest pop
+12.2%
Biggest drop
-6.7%

Standard deviation of the close-to-close move over the last 7 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-13 miss -0.75 -1.77 -134.4% -2.9% -6.7% +1.1%
2026-05-13 beat -1.54 -1.46 +5.2% +2.3% +4.0% +2.1%
2026-03-16 miss -1.19 -1.39 -16.8% -2.9% -3.4% -14.2%
2025-11-12 miss -0.85 -1.22 -44.1% +2.3% +1.7% +5.5%
2025-08-12 miss -1.06 -1.25 -17.9% -2.7% +6.7% +6.3%
2025-05-15 beat -1.03 -0.80 +22.3% +5.1% +12.2% +31.9%
2024-11-12 beat -9.30 -5.02 +46.0% -0.9% -3.1% -31.8%

Not investment advice.